Head-to-head · Cost-Efficiency Index
MEDGm vs OurView Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
MEDGm
Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Visit MEDGmOurView Health
Cost-first shoppers who want low-cost compounded GLP-1 via a membership savings model.
Visit OurView HealthThe verdict
OurView Health takes it, leading the Cost-Efficiency Index 62 to 60. OurView (OurView Health) is a 100% online multi-vertical telehealth service with an Our View Savings Club membership offering pharmacy-direct pricing on U.S.-compounded medications. MEDGm still earns a C — Readers who want the dispensing pharmacies and the prescribing practices named, and who will price the second month rather than the first.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs OurView Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | MEDGm | OurView Health |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 62/100 |
| Semaglutide / mo | $299/mo month-to-month (the advertised $179 is the first month only, after an automatically applied coupon) | $75/mo (starting dose, compounded) |
| Tirzepatide / mo | $399/mo month-to-month (the advertised $279 is the first month only) | $135/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $3,588 | $900 |
| Tirzepatide / yr (modeled) | $4,788 | $1,620 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #203 | #210 |
MEDGm
60/100Where the value is
- Names all four pharmacy partners in its terms, with street addresses, phone numbers and websites, and says which compounding classes they operate under
- Names seven prescribing professional corporations on its consent page rather than referring to an unnamed medical group
- Publishes the full ladder for three GLP-1 routes — injection, oral tablet and tirzepatide — at one, three, six and twelve months
The tradeoffs
- "Starting at $179" is a first-month rate produced by an automatically applied coupon; the standing month-to-month price is $299, and the same shape applies to the oral tablet and to tirzepatide
- The treatments FAQ says "your price never increases" on a plan whose price increases by $120 at the first renewal
OurView Health
62/100Where the value is
- Low starting prices via the Savings Club — compounded semaglutide from $75, tirzepatide from $135
- Clear product pricing with no contracts; medication shipped to your door (30-day supply)
- Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)
The tradeoffs
- A comparison table on the site quotes $90 'without membership' against $75 'with membership' while the product cards say 'No membership' and the cart charges $75 without one — the provider contradicts itself on whether a membership exists
- Both figures are starting-dose rates; the cost of a titrated dose is published as a ladder rather than a single price
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.